<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Relenza from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Relenza news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 12:23:32 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Relenza" rel="self" type="application/rss+xml" />

	
<item><title>Hong Kong reports 67th fatal case of A/H1N1 flu</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039703&amp;HITNO=0&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039703&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538331438%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039703&amp;HITNO=0&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039703&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538331438%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>People's Daily Online:</description></item>
<item><title>HK reports 67th fatal case of A/H1N1 flu</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039550&amp;HITNO=1&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039550&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538207331%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039550&amp;HITNO=1&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039550&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538207331%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>China Org:</description></item>
<item><title>Hong Kong reports 67th fatal case of A/H1N1 flu</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039321&amp;HITNO=2&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039321&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538023127%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039321&amp;HITNO=2&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039321&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538023127%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>People's Daily Online:</description></item>
<item><title>MELBOURNE-based Biota expects a 35.3% jump in Relenza royalties for the December quarter after GlaxoSmithKline</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035184&amp;HITNO=3&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035184&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536152046%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035184&amp;HITNO=3&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035184&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536152046%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>BioTechnologyNews.net:</description></item>
<item><title>USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034035&amp;HITNO=4&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034035&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535569603%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034035&amp;HITNO=4&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034035&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535569603%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>Roche licenses new flu-fighting technology</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033222&amp;HITNO=5&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033222&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535076768%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033222&amp;HITNO=5&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033222&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535076768%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Trade Arabia:</description></item>
<item><title>NexBio Granted United States Patent Covering DAS181 (Fludase(R) *) and its Use for Prevention and Treatment of</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032663&amp;HITNO=6&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032663&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534756733%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032663&amp;HITNO=6&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032663&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534756733%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Choice:</description></item>
<item><title>GlaxoSmithKline Q4 profit up 66 pct</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4027721&amp;HITNO=7&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4027721&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532314191%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4027721&amp;HITNO=7&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4027721&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532314191%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>KCAU-TV:</description></item>
<item><title>NexBio Granted United States Patent Covering DAS181 (Fludase) and its Use for Prevention and Treatment of Infl</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4031078&amp;HITNO=8&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4031078&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533980518%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4031078&amp;HITNO=8&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4031078&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533980518%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>NexBio Granted United States Patent Covering DAS181 (Fludase) and its Use for Prevention and Treatment of Infl</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4030939&amp;HITNO=9&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4030939&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533901877%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4030939&amp;HITNO=9&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4030939&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533901877%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>UPDATE 1-Roche licenses new flu-fighting technology</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4030813&amp;HITNO=10&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4030813&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533831428%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4030813&amp;HITNO=10&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4030813&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533831428%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Reuters:</description></item>
<item><title>UK job cuts at GSK</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029596&amp;HITNO=11&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029596&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533202240%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029596&amp;HITNO=11&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029596&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533202240%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>The Manufacturer:</description></item>
<item><title>Relenza royalty for December 2009 quarter</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4026975&amp;HITNO=12&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4026975&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2531612992%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4026975&amp;HITNO=12&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4026975&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2531612992%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>GlaxoSmithKline Q4 profit up 66 pct</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4026329&amp;HITNO=13&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4026329&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2530652232%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4026329&amp;HITNO=13&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4026329&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2530652232%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>WECT TV-6:</description></item>
<item><title>Daiichi Sankyo: new influenza drug may boost flagging Japanese market</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4026833&amp;HITNO=14&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4026833&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2531375807%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4026833&amp;HITNO=14&amp;MSIZE=208&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Relenza&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4026833&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2531375807%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PipelineReview:</description></item>
</channel></rss>